Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
Rapport Therapeutics announced it will host a virtual Key Opinion Leader (KOL) event on September 22, 2026, featuring experts Dr. Mauricio Tohen and Dr. Gary Sachs to discuss the unmet need in bipolar mania. The event will focus on the mechanistic rationale for RAP-219, the Company's TARPγ8-specific AMPA receptor negative allosteric modulator currently in development.
Key figures
- Phase Of Trial
- Phase 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.